These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 36982693)

  • 21. Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective.
    Yi S; Wang L; Wang H; Ho MS; Zhang S
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain Inflammation and Intracellular α-Synuclein Aggregates in Macaques after SARS-CoV-2 Infection.
    Philippens IHCHM; Böszörményi KP; Wubben JAM; Fagrouch ZC; van Driel N; Mayenburg AQ; Lozovagia D; Roos E; Schurink B; Bugiani M; Bontrop RE; Middeldorp J; Bogers WM; de Geus-Oei LF; Langermans JAM; Verschoor EJ; Stammes MA; Verstrepen BE
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
    Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
    Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.
    Tozzi A; Sciaccaluga M; Loffredo V; Megaro A; Ledonne A; Cardinale A; Federici M; Bellingacci L; Paciotti S; Ferrari E; La Rocca A; Martini A; Mercuri NB; Gardoni F; Picconi B; Ghiglieri V; De Leonibus E; Calabresi P
    Brain; 2021 Dec; 144(11):3477-3491. PubMed ID: 34297092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Models of α-synuclein aggregation in Parkinson's disease.
    Giráldez-Pérez R; Antolín-Vallespín M; Muñoz M; Sánchez-Capelo A
    Acta Neuropathol Commun; 2014 Dec; 2():176. PubMed ID: 25497491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Intersection of Parkinson's Disease, Viral Infections, and COVID-19.
    Rosen B; Kurtishi A; Vazquez-Jimenez GR; Møller SG
    Mol Neurobiol; 2021 Sep; 58(9):4477-4486. PubMed ID: 34033061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-Synuclein Dopaminylation Presented in Plasma of Both Healthy Subjects and Parkinson's Disease Patients.
    Zhao H; Huang S; Palanisamy S; Wang C; Rainer G; Zhang X
    Proteomics Clin Appl; 2020 Sep; 14(5):e1900117. PubMed ID: 32538547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex.
    Palmas MF; Etzi M; Pisanu A; Camoglio C; Sagheddu C; Santoni M; Manchinu MF; Pala M; Fusco G; De Simone A; Picci L; Mulas G; Spiga S; Scherma M; Fadda P; Pistis M; Simola N; Carboni E; Carta AR
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner.
    Pham CL; Leong SL; Ali FE; Kenche VB; Hill AF; Gras SL; Barnham KJ; Cappai R
    J Mol Biol; 2009 Apr; 387(3):771-85. PubMed ID: 19361420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral mimetic priming enhances α-synuclein-induced degeneration: Implications for Parkinson's disease.
    Olsen LK; Cairns AG; Ådén J; Moriarty N; Cabre S; Alamilla VR; Almqvist F; Dowd E; McKernan DP
    Brain Behav Immun; 2019 Aug; 80():525-535. PubMed ID: 31029796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
    Çınar E; Tel BC; Şahin G
    Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers.
    Lee HJ; Baek SM; Ho DH; Suk JE; Cho ED; Lee SJ
    Exp Mol Med; 2011 Apr; 43(4):216-22. PubMed ID: 21415592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated Rebels.
    Sian-Hulsmann J; Riederer P
    Cells; 2021 Mar; 10(3):. PubMed ID: 33803185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction.
    Ginns EI; Mak SK; Ko N; Karlgren J; Akbarian S; Chou VP; Guo Y; Lim A; Samuelsson S; LaMarca ML; Vazquez-DeRose J; Manning-Boğ AB
    Mol Genet Metab; 2014 Feb; 111(2):152-62. PubMed ID: 24388731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of an Alternatively Spliced α-Synuclein Isoform That Generates a 41-Amino Acid N-Terminal Truncated Peptide, 41-syn: Role in Dopamine Homeostasis.
    Vinnakota RL; Yedlapudi D; Manda KM; Bhamidipati K; Bommakanti KT; RangaLakshmi GS; Kalivendi SV
    ACS Chem Neurosci; 2018 Dec; 9(12):2948-2958. PubMed ID: 29996045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
    Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
    Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC
    J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.